Given the contribution to HCC early recurrence from bigger tumor size and the elevated serum IL17 levels we combined the two factors to examine the risk of early recurrence using the Kaplan-Meier method (Figure 1). This evidence concerns the gene IL17A and hepatocellular carcinoma.